About Event

What Can You Expect from the 2nd ADC Pharmacokinetics & Clinical Pharmacology Summit?

The FDA’s Project Optimus is changing the game, and ADC clinical pharmacology guidelines are evolving fast. Getting the dose right, balancing safety and efficacy, has never been more crucial. 

Modern ADCs aren’t simple - they’re novel conjugates, dual payloads, and combination therapies that push the boundaries of traditional dosing. At the 2nd ADC Pharmacokinetics & Clinical Pharmacology Summit, 40+ experts in PKPD, pharmacometrics, modeling, and bioanalysis will come together to share insights, tackle real-world challenges, and help you define optimal dosing strategies from day one. 

Don’t miss the chance to collaborate, learn, and accelerate the path to safer, more effective ADCs for patients. Join us this December in Boston to really be able to speak to likeminded individuals and work together to advance ADC dosing! 

Unmissable Event Highlights:

Examine approaches to dosing novel conjugates

Investigate non-traditional payloads and bispecific ADCs to understand how unique PK properties influence clinical outcomes, with insights from AstraZeneca 

Learn from real-world case studies

Explore dose optimization and adjustment through modeling and simulation, presented by Astellas Pharma

Investigate tumor internalization mechanisms

Join AbbVieDaichii Sankyo using bioanalytical methods to assess structural integrity and DAR for deeper insights into drug clearance

Advance clinical dosing strategies

Apply QSP platforms with Novartis to rigorously evaluate the predictive value of computational modeling

Close the translational gap in PK/PD

Leverage AI and enhance ADME parameter understanding with Sutro Biopharma

Download the Full Event Guide to Discover:

  • Hands-on workshops exploring the latest in novel conjugates and combination therapies
  • Insider talks from AstraZeneca, Daiichi Sankyo, Genentech, and other industry leaders
  • Interactive roundtables where your voice drives the discussion
  • Premium networking opportunities to connect with the people shaping ADC innovation
October 6-8, 2025 Chicago, IL

Attending Companies Include:

abbvie logo
Astellas logo
AstraZeneca logo
bicycle logo
Daiichi-Sankyo Logo
Genetech logo
Gilead logo
GSK Logo
Heidelberg Pharma Logo
Novartis Logo
Sutro Biopharma